Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis

Showing 15 posts of 824 posts found.

Novartis image

Novartis to acquire Fougera for $1.5 billion

May 3, 2012
Sales and Marketing Fougera, Novartis, dermatology, generics, gilenya

Novartis will acquire the dermatology generics firm Fougera for $1.53 billion in cash.  Novartis’ generic unit Sandoz is conducting the …

News
Shell oil website

Roche and Novartis have best websites

May 3, 2012
Medical Communications Bowen Craggs & Co, Novartis, Pfizer, Roche, Shell, digital, web

A new survey of leading international companies has found Roche and Novartis have the best websites in the pharma sector.  …

News

Novartis will restart production at Lincoln plant in May

May 1, 2012
Manufacturing and Production FDA, GMP, Lincoln, Nebraska, Novartis, manufacturing

Novartis chief executive Joe Jimenez has said that production at the firm’s troubled consumer health plant in Lincoln, Nebraska, will …

News

Novartis Q1 earnings slide down

April 26, 2012
Sales and Marketing Novartis, Q1, Sandoz, generics, gilenya

Generic competition and problems at a US plant were among the reasons why Novartis’ sales and profit dipped in the …

News

GMC won’t relax off-label prescribing guidelines

April 25, 2012
Sales and Marketing GMC, Lucentis, Novartis, Roche, avastin, off label, off-label

The GMC has decided not to relax guidelines on off-label prescribing when a licensed alternative exists. The GMC’s current rules …

News
Novartis image

Novartis to invest $550m in new Swiss plant

April 24, 2012
Manufacturing and Production GSK, Novartis, manufacturing and production

Novartis has unveiled plans to build a new manufacturing facility at its site in Stein, Switzerland, just weeks after calling …

News
Lucentis image

Charity challenges government on Avastin for wet AMD

April 24, 2012
Sales and Marketing Lucentis, Novartis, Roche, avastin, off label, off-label, wet AMD

A leading patient group has called on the government to get to grips with the issue of off-label prescribing, as …

News
Gilenya

New safety warnings recommended for Gilenya

April 20, 2012
Medical Communications, Sales and Marketing EMA, Novartis, gilenya

A safety review of Novartis’ MS treatment Gilenya has concluded the drug should stay on the market, but that patients …

News
Bayer image

Bayer cancer drug meets Phase III goal

April 3, 2012
Research and Development, Sales and Marketing Bayer, Cancer, Glivec, Novartis, phase III, regorafenib

Bayer’s stomach cancer pill regorafenib has significantly improved progression free survival in late-stage patients. Results from the Phase III trial …

News

Novartis to construct pharma plant in Turkey

April 2, 2012
Manufacturing and Production Novartis, Turkey, manufacturing

Novartis has selected Turkey as its headquarters for central Asia, the Middle East and Africa and intends to set up …

News
Novartis HQ

Novartis signs experimental eye drug deal

March 19, 2012
Research and Development, Sales and Marketing Novartis, ThromboGenics, vitreomacular adhesion

Novartis will develop an experimental eye drug with ThromboGenics in a pact worth nearly $500 million.  The deal has been …

News
Novartis image

Novartis Indian patent battle nears conclusion

March 7, 2012
Sales and Marketing Glivec, HIV, India, Novartis, patents

A long-running battle over the patent of cancer treatment Glivec in India is about to reach its dramatic climax.India’s Supreme …

News

Novartis appoints Brian McNamara to division head of OTC business

March 1, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Brian McNamara, Novartis, OTC

Novartis has appointed Brian McNamara to the position of division head of its OTC (Over-the-Counter) business with immediate effect. McNamara …

Appointment
GSK picture

GSK recalls Novartis’ blood pressure drug

February 28, 2012
Manufacturing and Production DynaCirc CR, GSK, Novartis

GlaxoSmithKline is the latest company to be affected by manufacturing glitches at Novartis’ troubled facility in Lincoln, Nebraska, having been …

News
Glivec

Glivec cleared for longer use in GIST patients

February 28, 2012
Sales and Marketing Europe, GIST, Gleevec, Glivec, Novartis

Glivec has gained EU approval for extended use after surgery for adults with KIT (CD117)-positive gastrointestinal stromal tumours (GIST).The drug …

News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026